Home › Funds › Squadron Capital Management LLC › CUE

Squadron Capital Management LLC position in CUE

CUE BIOPHARMA · Health Care

Squadron Capital Management LLC reported holding 50,000 shares of CUE (CUE BIOPHARMA) in its Q2 2026 13F filing — a position valued at US$1.6M, representing 0.62% of its reported portfolio and ranking #31 among its reported holdings. Squadron Capital Management LLC first reported this position in Q2 2026.

Latest position (Q2 2026)50.00K sh
Reported value held$1.58M
Portfolio Weight0.62%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Squadron Capital Management LLC's CUE position evolved

Squadron Capital Management LLC first disclosed a stake in CUE in Q2 2026 at 50,000 shares (US$1.6M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 50.00K $1.58M New

About CUE and 13F data

CUE (CUE BIOPHARMA) is a Health Care company. 28 other funds we track also report a position in CUE — the largest reported positions include Bleichroeder LP (US$11.7M), Tetragon Partners GP Ltd (US$3.0M), Lion Point Capital, LP (US$1.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CUE

All CUE fund holders →

FAQ

How long has Squadron Capital Management LLC held CUE?

Squadron Capital Management LLC has disclosed CUE holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Squadron Capital Management LLC's current position in CUE?

As of Q2 2026, Squadron Capital Management LLC holds 50.00K shares of CUE (CUE BIOPHARMA), valued at $1.58M, representing 0.62% of its reported portfolio and ranking #31.

Has Squadron Capital Management LLC been buying or selling CUE?

In the latest 13F filing (Q2 2026), Squadron Capital Management LLC newly opened its position in CUE.

Which other funds hold CUE?

Other major institutional holders of CUE include Bleichroeder LP, Tetragon Partners GP Ltd, Lion Point Capital, LP, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.